In this Saturday, Jan. 19, 2013 photo. a college student kicks a soccer ball in front of Chinese characters on the fence reading "good health" in Beijing. Despite its formidable performance in recent Olympic Games, China has found itself in a crisis of declining fitness among its youngsters. (AP Photo/Alexander F. Yuan)
Taro Pharma says sale to Sun Pharma is canceled
Published: 07:55:36 PM, Fri 08 February 2013 UTC
NEW YORK (AP) — Taro Pharmaceutical Industries Ltd. said Friday it won't be acquired by Sun Pharmaceutical Industries Ltd., terminating an agreement from August.
Sun already owns most of Taro, and it agreed to buy the remaining third of the company for about $580.6 million, or $39.50 per share. Sun made an offer of $24.50 per share in late 2011, and the companies have periodically discussed an acquisition since mid-2007.
Taro is based in Israel, and Sun in India.
Shares of Taro are trading well above the proposed acquisition price and they rose further on the news Friday. The stock gained $1.61, or 3.2 percent, to $52.16. Earlier it reached a nine-year high of $53.28. The shares last traded at that price in August 2003.
Tags:
ap, science_technology, shareholder, agreement, percent, friday, companies, sun, stock, israel, company, sale, stock market, offer, shares, share, new york, pharmacology, pharmacy, taro, pharmaceutical industries ltd., taro pharmaceutical industries, proposed acquisition price, sun pharmaceutical industries, nine-year high, mid-2007, sun pharmaceutical
